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Abstract 
Background: Formate converted from  CO2 reduction has great potential as a sustainable feedstock for biological 
production of biofuels and biochemicals. Nevertheless, utilization of formate for growth and chemical production 
by microbial species is limited due to its toxicity or the lack of a metabolic pathway. Here, we constructed a formate 
assimilation pathway in Escherichia coli and applied adaptive laboratory evolution to improve formate utilization as a 
carbon source in sugar‑free conditions.
Results: The genes related to the tetrahydrofolate and serine cycles from Methylobacterium extorquens AM1 were 
overexpressed for formate assimilation, which was proved by the 13C‑labeling experiments. The amino acids detected 
by GC/MS showed significant carbon labeling due to biomass production from formate. Then, 150 serial subcul‑
tures were performed to screen for evolved strains with improved ability to utilize formate. The genomes of evolved 
mutants were sequenced and the mutations were associated with formate dehydrogenation, folate metabolism, 
and biofilm formation. Last, 90 mg/L of ethanol production from formate was achieved using fed‑batch cultivation 
without addition of sugars.
Conclusion: This work demonstrates the effectiveness of the introduction of a formate assimilation pathway, com‑
bined with adaptive laboratory evolution, to achieve the utilization of formate as a carbon source. This study suggests 
that the constructed E. coli could serve as a strain to exploit formate and captured  CO2.
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Background
The increased level of atmospheric carbon dioxide  (CO2) 
is the main cause of global warming. Accordingly, car-
bon dioxide capture and storage (CCS) technology is 
considered as an important research area for a sustain-
able environment. Among the options available, hydro-
gen-dependent conversion of  CO2 into formate has 
the advantage of storing and transporting hydrogen as 
well as utilizing captured  CO2 [1–5]. These reactions of 
 CO2 reduction have been extensively studied using both 
chemical and biological catalysts, facilitating an easier 
approach for formate production [6–9]. In particular, 
cost-effective formate production can be regarded as 
a potential way of sequestering  CO2 [10–12]. This in 
turn has drawn attention to formate as a promising car-
bon source for use in the biological production of use-
ful chemicals [13–16]. Although native formatotrophic 
microbes are able to convert formate into biomass or 
biochemicals, utilization of formate as a carbon source 
in bioprocesses is limited owing to technical difficul-
ties in the genetic modification of native formatotrophs 
or because of their low biomass and product yields [5]. 
It is therefore crucial to focus on commonly used indus-
trial organisms that have higher growth rates and are 
easy to genetically manipulate for formate consumption. 
For example, metabolic engineering has been recently 
attempted in Escherichia coli to increase formate fixation 
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abilities, because of the ease of genetic manipulation in 
this species [17, 18].
In this study, we developed E. coli mutant strains 
capable of utilizing formate as a carbon source in sugar-
free conditions, through the introduction of the tet-
rahydrofolate cycle and serine utilizing pathway genes 
(Fig. 1). This pathway was chosen because the enzymes 
in the pathway are oxygen-tolerant and serine can be 
easily accessible to the central carbon metabolism [14, 
19]. Therefore, the related genes were cloned from 
Methylobacterium extorquens AM1 and overexpressed. 
In addition, adaptive laboratory evolution (ALE) [20, 
21] was carried out until the strain could utilize for-
mate and grow at a significant rate. After conducting 
the ALE experiment for 150 serial subcultures, mutant 
strains with the desired phenotype were screened 
for and their genomes were sequenced. Based on the 
genome sequences, a few mechanisms, possibly respon-
sible for increased formate utilization and resistance to 
Fig. 1 Scheme of E. coli‑based synthetic formatotrophic strain development. The formate assimilation pathways were constructed in E. coli 
and adaptive laboratory evolution was carried out with 150 serial subcultures. The red arrows indicate engineered pathways and the black 
arrows indicate innate pathways. THF, tetrahydrofolate;  N10‑fTHF, 10‑formyl tetrahydrofolate; 5,10‑CH+‑THF, 5,10‑methenyl tetrahydrofolate; 
5,10‑CH2‑THF, 5,10‑methylene tetrahydrofolate; 2PGA, 2‑phosphoglycerate; PEP, phosphoenolpyruvate; Pyr, pyruvate; OAA, oxaloacetate; FtfL, 
formate‑tetrahydrofolate ligase; Fch, methenyl tetrahydrofolate cyclohydrolase; MtdA, methylene‑tetrahydrofolate dehydrogenase; GlyA, serine 
hydroxymethyltransferase; Sga, serine‑glyoxylate transaminase; Hpr, hydroxypyruvate reductase; Gck, glycerate kinase
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formate toxicity, were examined. Finally, the resulting 
E. coli were engineered to convert formate into ethanol.
Results and discussion
Construction of a formate assimilation pathway in E. coli
The serine cycle pathway, one of the formate assimilation 
pathways, has the advantage that the serine is relatively 
easily accessible to central carbon metabolism and the 
enzymes involved in this serine utilizing pathway show 
oxygen tolerance [19]. Therefore, we attempted the con-
struction of three pathway modules to implement for-
mate assimilation through the serine utilizing pathway 
in E. coli (Fig.  1) (i) the THF (tetrahydrofolate) cycle 
[15, 24] composed of formate-tetrahydrofolate ligase 
(FtfL), methenyl tetrahydrofolate cyclohydrolase (Fch), 
and methylene-tetrahydrofolate dehydrogenase (MtdA); 
(ii) the serine synthesis enzyme, serine hydroxymethyl-
transferase (GlyA), from 5,10-CH2-THF and glycine [15, 
25]; and (iii) the pathway converting serine to phospho-
glyceric acid (PGA) for bacterial growth, comprising 
serine-glyoxylate transaminase (Sga), hydroxypyruvate 
reductase (Hpr), and glycerate kinase (Gck). After the 
insertion of these modules, E. coli strains were cultured 
in formate M9 minimal medium to test their ability 
to utilize formate as a carbon source (Fig.  2). Because 
no detectable biomass formation was observed when 
inoculations were made at an OD of 0.1 (data not shown), 
the initial optical density (iOD) was increased to 0.7.
The wild-type strain did not show any formate assimi-
lation ability, resulting in no biomass formation (Fig. 2a). 
When FtfL from M. extorquens AM1 was overexpressed, 
some extent of formate utilization was observed (Fig. 2b). 
The EMK strain, overexpressing the three genes of the 
THF cycle, ftfL, fch, and mtdA from M. extorquens AM1, 
was able to assimilate formate but only at a very low level 
(Fig. 2c). The insertion of the second and third modules 
in this strain did not result in an additional increase in 
formate assimilation (data not shown), possibly because 
the methyl unit in the THF cannot be converted to serine 
efficiently in E. coli.
To resolve this limitation, gcvP (Gene ID: 947,394 
[Genbank]), encoding one of the components of the gly-
cine cleavage system (GCS) [26, 27], was deleted. The 
resulting strain, EMK00, displayed similar formate uti-
lization compared with its parental strain when glycine 
was supplied in the medium to induce serine biosynthesis 
[18] (Fig. 2d). To enhance the efficiency of the serine syn-
thesis, glyA was cloned from M. extorquens and overex-
pressed (EMK01 strain), which resulted in an increased 
ability to utilize formate compared to the EMK00 strain 
(Fig. 2e). In addition, the third module, based on the sga, 
hpr, and gck genes from M. extorquens, was introduced 
Fig. 2 Formate utilization and biomass production at various stages of E. coli strain development with iOD of 0.7. The strains grew in formate 
M9 minimal medium (a–c) and formate M9 minimal medium supplemented with 1 g/L of glycine (d–f). Wild‑type: Escherichia coli BL21; EM: FtfL 
overexpression in E. coli; EMK: FtfL, MtdA and Fch overexpression in E. coli; EMK00: gcvP knockout in the EMK strain; EMK01: GlyA overexpression 
in the EMK00 strain; EMK02: Sga, Hpr, and Gck overexpressions in the EMK01 strain; Black circles: Optical density at 600 nm (OD600); White circles: 
formate concentrations
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into EMK01 to convert serine into PGA (Fig.  2f ). Even 
though this strain (EMK02) showed higher formate 
uptake and growth rates compared to the other strains, 
its growth was still very limited.
To make sure that formate was used to produce bio-
mass through the introduction of a formate assimilation 
pathway, we did 13C-labeling experiments [28, 29]. Of 
the 20 amino acids, 11 were detected by GC/MS, which 
showed significant carbon labeling due to biomass pro-
duction from formate. The pathways involved in the 
synthesis of the 11 amino acids in E. coli are shown in 
Fig.  3a. When 13C-labeled formate was supplied to the 
M9 minimal medium with 1 g/L glycine and amino acids 
from biomass were analyzed by GC/MS in the EMK02 
strain, significant proportions of amino acids [methio-
nine (28.4%), threonine (29.1%), serine (35.5%), aspar-
tate (29.1%), glutamate (36.1%), alanine (31.6%), etc.] 
(Fig.  3b)] contained 13C. Since the culture was initiated 
with an iOD of 0.7, a significant proportion of amino 
acids were derived from the inoculated cells, resulting in 
a high M0 proportion. Nevertheless, these 13C-labeling 
experiment results demonstrated that the E. coli strain 
with the serine utilizing pathway inserted was able to 
convert formate into biomass.
Adaptive laboratory evolution (ALE) of EMK02
The EMK02 strain, in which the formate assimilation 
pathway was established, still showed low formate utili-
zation. To overcome this limitation, adaptive laboratory 
evolution (ALE) [20, 30] was carried out until the desired 
phenotypes emerged. The EMK02 strain was cultured in 
modified EMK medium. Small amounts of yeast extract 
and glycine were supplied in order to achieve sufficient 
bacterial growth to subculture once every 24  h. The 
amount of yeast extract was gradually reduced, while 
the amount of formate was progressively augmented to 
enhance the formate utilization ability (Fig. 1). Adaptive 
laboratory evolution was carried out by 150 serial sub-
cultures and strains with the highest growth rate were 
selected at every 30th subculture. Formate uptake and 
growth rates of the strains, as assessed every 30th subcul-
ture, gradually increased and the strains selected after the 
60th and 150th serial subcultures showed significantly 
higher formate uptake and growth rates than their ances-
tors (Fig. 4a, b). These strains were named as EMK02A2 
and EMK02A5, respectively (Table 1).
For the initial experiments, bacteria were inoculated 
at an initial OD (iOD) of 0.7 to solve the low growth 
issue in the formate M9 minimal medium. However, as 
EMK02A2 and EMK02A5 showed significantly higher 
growth rate and formate utilization ability, these strains 
were inoculated at an iOD of 0.1 and their growth and 
formate uptake rates were compared with wild-type and 
EMK02 strains (Fig. 4c, d). The evolved strain EMK02A5 
showed strikingly different growth and formate uptake 
rates under these conditions. To ascertain the ability of 
EMK02A5 to utilize formate for biomass production, the 
strain was cultivated with 13C-labeled formate. An initial 
13C-labeling experiment was performed with an iOD of 
0.7 and an 8-h cultivation, and the results were compared 
with those obtained with the EMK02 and EMK02A2 
strains (Additional file  1: Figure S1). The strains that 
underwent longer ALE had a higher proportion of 
labeled amino acids, which indicated improved formate 
utilization and biomass production. Then, the fraction 
of labeled amino acids in the EMK02A5 was measured 
with an iOD of 0.1, after an 18-h cultivation. The labeled 
fractions were significantly higher when the iOD was 
0.1 (Fig. 4e). This was likely because of lower biomasses 
at inoculation under these conditions and, therefore, 
to a lower contribution of unlabeled amino acids from 
Fig. 3 Carbon‑labeling experiment with 13C‑labeled formate in the 
EMK02 strain. The pathway involved in the synthesis of amino acids 
in Escherichia coli (a). OAA, oxaloacetate; AcCoA, acetyl coenzyme 
A; Pyr, pyruvate; αKG, α‑ketoglutarate; PEP, phosphoenolpyruvate; 
PGA, phosphoglycerate; G3P, glycerate 3‑phosphate; E4P, erythrose 
4‑phosphate; Red arrows: amino acid synthetic pathway; Purple 
arrows: constructed formate assimilation pathway. The proportion 
of labeled amino acids in the EMK02 strain after 6‑h cultivation 
with 13C‑labeled formate in formate M9 minimal medium supplied 
with 1 g/L glycine at iOD of 0.7 (b). Mass isotopomer distribution is 
displayed in the stacked bar graph and M0–M8 denotes the number 
of incorporated 13C carbon atoms in proteinogenic amino acids
Page 5 of 12Kim et al. Biotechnol Biofuels          (2019) 12:207 
preexisting bacteria. The 13C-labeling results clearly 
showed significantly improved formate assimilation after 
150 ALE subcultures.
To verify the production of useful compounds from 
formate as the main carbon source, the ethanol pathway 
was overexpressed in the strains. Two genes, pdc from 
Zymomonas mobilis, encoding pyruvate decarboxylase 
(NCBI-Protein ID: AEH63551) and adhA from Lactococ-
cus lactis, encoding alcohol dehydrogenase (NCBI-Pro-
tein ID: NP_267964) were overexpressed [31]. Although 
ethanol was not detected in the cultures of the EMK02e-
tOH and EMK02A2etOH strains, it was produced by the 
EMK02A5etOH strain at a concentration of 90  mg/L, 
after 24-h incubation (Fig.  4f ). In addition, a higher 
Fig. 4 Formate uptake and specific growth rates of ALE mutants. The specific growth rate (a) and formate uptake rate (b) for screened ALE evolved 
strains, growing in formate M9 minimal medium supplied with glycine at iOD of 0.7. Comparison of bacterial growth (c) and formate utilization 
(d) of wild‑type (BL21) (black), EMK02 (yellow), EMK02A2 (blue), and EMK02A5 (red) in EMK medium at iOD of 0.1. The fractions of labeled amino 
acids in the EMK02A5 strain after 18‑h cultivation with 13C‑labeled formate at iOD of 0.1 (e). Ethanol production in different strains (f). Bars and 
dots represent titer and yield, respectively. The strains, EMK02etOH, EMK02A2etOH, and EMK02A5etOH, represented EMK02, EMK02A2, EMK02A5 
harboring plasmid for overexpression of pyruvate decarboxylase and alcohol dehydrogenase for ethanol production, respectively. The detailed 
description of strains is given in Table 1
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portion of labeled ethanol was detected in the fed-batch 
culture with 13C-labeled formate (Additional file 1: Figure 
S2). This finding confirmed that other useful biochemi-
cals or biofuels can be produced using formate in the 
absence of sugars.
Genome sequence analysis of ALE strains
To gain insights into the phenotype changes in ALE-
mutant strains, whole genome DNA sequencing was 
carried out for the EMK02A2 and EMK02A5 strains. 
Genome sequencing was conducted twice and only the 
mutations showing the same results in both sequencing 
sessions were selected. In addition, only mutations with 
sequencing quality score above the reference level were 
considered. When the genome of EMK02A2 was com-
pared to that of the wild-type, E. coli BL21 (DE3), 54 
mutations were detected. Since gcvP had been deleted 
from the EMK02 genome, this gene was not included 
in the mutation table. No mutations were detected 
in the pZAM02 and pCDM02 plasmids. Among the 
identified mutations, 40 were found to occur in cod-
ing regions, including 19 non-synonymous, 19 synony-
mous, and 2 frameshift mutations (Additional file  1: 
Table  S3). Notably, 90% of these mutations involved 
seven different metabolic pathways and two individual 
genes. They are folate metabolism, formate hydrogen 
Table 1 Bacterial strains and plasmids used in this study
Name Description Reference
Strains
 DH5α RBC
 Wild‑type BL21(DE3) KCTC 
 EM BL21(DE3) harboring pZAM This study
 EMK EM harboring pZAM01 This study
 EMK00 EMK ΔgcvP This study
 EMK01 EMK00 harboring pZAM02 This study
 EMK02 EMK00 harboring pZAM02 and pCDM02 This study
 EMK02A2 ALE mutant from EMK02 for 60th serial subcultures This study
 EMK02A5 ALE mutant from EMK02 for 150th serial subcultures This study
 vA5f EMK02A2 harboring pZSfimCD This study
 vA5y EMK02A2 harboring pZSydeH This study
 vA5h EMK02A2 harboring pZShtrE This study
 vA5c EMK02A2 harboring pZScsgD This study
 EMK02etOH EMK02 harboring pZSetOH This study
 EMK02A2etOH EMK02A2 harboring pZSetOH This study
 EMK02A5etOH EMK02A5 harboring pZSetOH This study
Plasmids
 pZA31MCS p15A ori PLtetO‑1 CmR Expressys
 pZS21MCS pCS101 ori PLtetO‑1 KanR Expressys
 pCDFDuet‑1 Double T7 promoter, CloDF13 ori, SmR Novagen
 pKD4 FRT flanked resistance cassette involved vector, oriRγ, KmR Datsenko 
and Wan‑
ner [42]
 pRedET Red recombinase expression plasmid, repA, pSC101ori, PBAD, gam, beta alpha, recA, tetR Gene Bridge
 707FLP Flippase expression plasmid, pSC101ori, repA, cl578, FLPe, tetR Gene Bridge
 pZAM pZA31MCS containing gene ftfL from M. extorquens AM1 This study
 pZAM01 pZAM containing genes mtdA and fch from M. extorquens AM1 This study
 pZAM02 pZAM01 containing gene glyA from M. extorquens AM1 This study
 pCDM02 pCDFDuet‑1 containing genes sga, hpr and gck from M. extorquens AM1 This study
 pZSetOH pZS21MCS containing genes pdc from Z. mobilis and adhA from L. lactis This study
 pZSfimCD pZS21MCS containing genes fimC and fimD from E. coli This study
 pZSydeH pZS21MCS containing gene ydeH from E. coli This study
 pZShtrE pZS21MCS containing gene htrE from E. coli This study
 pZScsgD pZS21MCS containing gene csgD from E. coli This study
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lyase regulation, ABC transport, DNA packing, panto-
thenate and CoA biosynthesis, DNA mismatch repair, 
stress response, lactate dehydrogenase, and carbamoyl-
transferase. Each pathway and metabolism are referred 
to KEGG functional orthologs (KO) and the pathway 
in KEGG (http://www.genom e.jp/kegg/). As folate 
metabolism is directly associated with the THF cycle 
of the formate assimilation pathway [15] and formate 
hydrogen lyase enhances formate consumption [32], 
we hypothesized that the mutations in the above-men-
tioned pathways accounted for most of the phenotypic 
changes observed in the EMK02A2 strain. Among the 
folate metabolism mutations, a frameshift mutation 
was found at the first codon of metF (Gene ID: 948432 
[Genbank]), which codes for methylenetetrahydro-
folate reductase and is the rate-limiting enzyme in the 
THF cycle (Fig.  5a) [27, 33] resulting in a stop codon 
in the third position. In addition, point mutations 
were detected in the coding regions of purU (Gene ID: 
945827 [Genbank]), the formyltetrahydrofolate defor-
mylase; purT, (Gene ID: 946368 [Genbank]) and purN 
(Gene ID: 946973 [Genbank]), the phosphoribosylglyci-
namide formyltransferases (Additional file 1: Table S3). 
They have major roles in balancing the pools of tetrahy-
drofolate and 10-formyl  tetrahydrofolate for the pro-
duction of purines [25]. As previously mentioned, metF 
presented a frameshift mutation in EMK02A2, causing 
loss of function, and non-synonymous mutations were 
found in purU, purT, and purN. For these reasons, we 
hypothesized that the mutations in THF cycle-related 
genes led to improved formate assimilation via an 
increased availability of 5,10-methylene  tetrahydro-
folate. In addition, mutations were found in the coding 
regions of hycA (Gene ID: 947193 [Genbank]) and fnr 
(Gene ID: 945908 [Genbank]), which are involved in 
the regulation of formate hydrogen lyase (Fig. 5b). The 
latter enzyme converts formate to carbon dioxide and 
hydrogen, which might be important for the efficient 
utilization of formate in terms of hydrogen generation 
and reducing the formate-induced toxic effect. This can 
be performed by the formate hydrogen lyase complex 
that consists of two membrane-bound enzymes—for-
mate dehydrogenase-H (FDH-H) and hydrogenase 3 
(Hyd-3) [34]. Therefore, we suggested a possibility that 
the mutations in hycA and fnr reduced the activities of 
Fig. 5 Functional confirmation of the mutations in EMK02A2. The tetrahydrofolate (THF) cycle pathway in E. coli (a). purN, encoding 
phosphoribosylglycinamide formyltransferase 1; purU, encoding formyltetrahydrofolate hydrolase; purT, encoding phosphoribosylglycinamide 
formyltransferase 2; metF, encoding 5,10‑methylenetetrahydrofolate reductase; DHF, dihydrofolate; THF, tetrahydrofolate; 5‑MTHF, 5‑methyl‑THF. 
The formate hydrogen lyase (FHL) system (b). FhlA is an activator of the FHL system, and FhlA is repressed by HycA and Fnr. Red letters: the deleted 
genes or proteins. Effects on growth and formate uptake rates by the deletions of one of the THF cycle genes or of the FHL system in EMK02 grown 
in EMK medium at iOD of 0.1 (c). Effects by deletions of two genes of the THF cycle and/or the THF system (d)
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these genes and increased the expression of formate 
hydrogen lyase.
To find out if the above mutations actually increased 
the ability to utilize formate, each of the relevant genes 
was deleted in the parental strain EMK02. Experiments 
conducted with a starting iOD of 0.1 in EMK medium 
demonstrated remarkable improvements of formate uti-
lization and growth rate in the strains EMK02 ∆purU, 
EMK02 ∆metF, and EMK02 ∆hycA (Fig.  5c). Next, 
we examined the effects of combined deletions of two 
genes among purU, metF, hycA, and fnr. Among the six 
mutants, the EMK02 ΔmetF ΔhycA strain grew well in 
EMK medium and displayed a growth rate as high as half 
that of the EMK02A2 strain. No significant changes were 
detected upon additional deletion of purU or fnr in the 
EMK02 ΔmetF ΔhycA strain (data not shown).
A total of 34 mutations were additionally detected 
in strain EMK02A5 compared to the genome of strain 
EMK02A2, 23 of which were in coding regions and 
included 19 non-synonymous mutations, 3 synonymous 
mutations, and 1 stop-codon gained mutation (Addi-
tional file  1: Table  S4). The mutations occurring as a 
result of 90 additional serial subcultures in EMK02A2 
were all in the coding regions of the genes involved in 
seven metabolic pathways. These pathways are related to 
peptidoglycan biosynthesis, the general secretion path-
way, S-formylglutathione hydrolase, aldehyde dehydro-
genase, diguanylate cyclase, fimbriae metabolism, and 
flagellar biosynthesis. Among them, diguanylate cyclase, 
fimbriae metabolism, and flagellar biosynthesis are 
known to be associated with bacterial mobility and bio-
film formation [35]. Biofilm biosynthesis is affected by 
the metabolism of peptidoglycans (PG), the main com-
ponent of the cell wall and the biofilm [36], and by the 
expression of fimbrial proteins, leading to aggregation 
of bacterial cells [37]. In EMK02A5, non-synonymous 
point mutations were found in the coding regions of fimC 
(Gene ID: 948843 [Genbank]), fimD (Gene ID: 948844 
[Genbank]), htrE (Gene ID: 944819 [Genbank]), and 
flgL (Gene ID: 945646 [Genbank]). In addition, to form 
a matrix of bacterial microcolonies, the motility factors 
must be inhibited. The genes encoding regulators of bio-
film formation, csgD (Gene ID: 949119 [Genbank]) and 
ydeH (Gene ID: 946075 [Genbank]), also presented non-
synonymous point mutations in their coding regions. 
According to the results from the crystal violet stain-
ing assay (CVA), biofilm formation of EMK02A5 was 
increased by more than twofold compared to that of the 
EMK02 strain (Fig. 6). This result was in accordance with 
the results of SEM imaging, which showed increased 
biofilm formation by the EMK02A5 strain (Fig. 6c, d). It 
has been reported that biofilm formation is beneficial for 
bacteria as it may improve their tolerance toward toxic 
compounds [38–41]. We reasoned that the mutations in 
the genes related to biofilm formation, i.e., fimC, ydeH, 
htrE, and csgD, could account for this effect. Therefore, 
we individually overexpressed these genes in EMK02A2. 
All of the resulting strains showed a higher degree of bio-
film formation and formate utilization capability, when 
compared with the original strain (Fig. 6b). Among them, 
the vA5y strain, overexpressing the ydeH gene, proved to 
be the highest biofilm producer and displayed the strong-
est ability to utilize formate (Fig. 6b). The results showed 
that bacterial biofilm formation was closely related to 
formate utilization and suggested that increased biofilm 
formation ability was the most important determinant 
of the phenotypic differences between EMK02A2 and 
EMK02A5.
Conclusions
An E. coli strain capable of utilizing formate for biomass 
formation was constructed by overexpression of genes 
involved in the THF cycle and in serine utilization path-
ways. Adaptive evolution significantly improved bacterial 
ability to utilize formate as proven by 13C-formate tracing 
experiments and ethanol production. Genome sequences 
of the evolved strains allowed us to identify important 
machineries and pathways related to formate utilization 
ability, such as the THF cycle, the formate dehydroge-
nase complex, and biofilm formation. The optimization 
of these biochemical routes, combined with appropriate 
strategies of pathway engineering, is expected to generate 
synthetic E. coli formatotrophs.
Methods
Strains and plasmids
All strains and plasmids used in this study are presented 
in Table  1. The bacterial strain E. coli BL21 (DE3) was 
used as a host for constructing the synthetic formato-
troph, and E. coli DH5α was used for plasmid cloning. 
The two strains were purchased from KCTC (Daejeon, 
South Korea) and RBC (Banqiao, Taiwan), respectively.
The genes encoding formate-tetrahydrofolate ligase 
(ftfL, Gene ID: 240007055 [Genbank]), methylene-
tetrahydrofolate dehydrogenase (mtdA, Gene ID: 
240008346 [Genbank]), methenyl tetrahydrofolate cyclo-
hydrolase (fch, Gene ID: 240008347 [Genbank]), and ser-
ine hydroxymethyltransferase (glyA, Gene ID: 240009895 
[Genbank]) from M. extorquens AM1 were cloned into 
the pZA31MCS vector (Expressys, Ruelzheim, Germany), 
whereas the genes encoding serine-glyoxylate transami-
nase (sga, Gene ID: 240008344 [Genbank]), hydroxypyru-
vate reductase (hpr, Gene ID: 240008345 [Genbank]), 
and glycerate kinase (gck, Gene ID: 240009470 [Gen-
bank]) were cloned into the pCDFDuet-1 vector (Nova-
gen, Madison, WI). Other genes related to ethanol 
Page 9 of 12Kim et al. Biotechnol Biofuels          (2019) 12:207 
production or biofilm formation were cloned into the 
pZS21MCS vector (Expressys, Ruelzheim, Germany). 
The genes were amplified using the primers indicated in 
detail (Additional file 1: Table S1) and the NEB Q5 DNA 
polymerase and ligated by the Gibson Assembly Master 
Mix (New England Biolabs, MA, USA). The gene knock-
out experiment was carried out as previously reported 
[42], with λ-red recombination using the pRedET trans-
formed strains. PCR products with antibiotic resistance 
genes were generated by PCR with the primers (Addi-
tional file 1: Table S2) and pKD4 as a template, and FLP 
expression using the 707FLP plasmid (Gene Bridges, 
Heidelberg, Germany) was used for eliminating the anti-
biotic resistance genes. All the knockout mutations were 
confirmed by sequencing of the genomic regions.
Media and culture conditions
The engineered strains were constructed using Luria–
Bertani (LB) medium (10 g/L tryptone, 5 g/L yeast extract, 
and 10  g/L NaCl), while the mutant strains were cul-
tured in formate M9 minimal medium or EMK medium. 
The composition of formate M9 minimal medium was 
10  mM sodium formate, 0.241  g/L  MgSO4, 0.011  g/L 
 CaCl2, 6  g/L  Na2HPO4, 3  g/L  KH2PO4, 0.5  g/L NaCl, 
1 g/L  NH4Cl, 0.1%(v/v) of 1000× trace elements (27 g/L 
 FeCl3·6H2O, 2  g/L  ZnCl2·4H2O, 2  g/L  CaCl2·2H2O, 
2 g/L  Na2MoO4·2H2O, 1.9 g/L  CuSO4·5H2O, and 0.5 g/L 
 H3BO3) supplemented with 50  μg/mL chlorampheni-
col, 50  μg/mL kanamycin, 100  μg/mL spectinomycin, 
50  μg/mL ampicillin, and 10  μg/mL tetracycline, when-
ever needed. The medium with 1 g/L glycine and 0.2 g/L 
yeast extract added to the formate M9 minimal medium 
is defined as EMK medium. All reagents were purchased 
from Sigma-Aldrich (St. Louis, MO, USA).
The seed culture was incubated in 5  mL of culture 
media supplied with 3  g/L yeast extract overnight. The 
seed strains were pelleted by centrifugation at 3500 rpm 
for 10  min at 4  °C and washed once with M9 minimal 
medium. Next, they were resuspended with 50  mL of 
medium and incubated micro-aerobically in 250-mL 
flasks sealed with silicone stoppers at 37 °C with shaking 
at 250 rpm; 0.05 mM IPTG was added at the beginning of 
culture. For the formate utilization culture with high ini-
tial optical density (iOD), 1 g/L glycine was added to the 
formate M9 minimal medium and the iOD was adjusted 
to 0.7. For other cultivations, EMK medium was utilized 
Fig. 6 Functional confirmation of mutations in strain EMK02A5. Normalized biofilm formation measured by Crystal Violet assay was compared to 
the specific growth rates of the strains in EMK medium at iOD of 0.1 among different stages of ALE strains (a) and among the strains overexpressing 
genes related to biofilm formation in EMK02 (b). The names, vA5f, vA5y, vA5h, and vA5c, in the x‑axis represent the strains with overexpression of 
fimCD, ydeH, htrE, and csgD, respectively, in EMK02A2. SEM images showing the biofilm formation of EMK02A2 (c) and EMK02A5 (d)
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and the iOD was adjusted to 0.1. For fed-batch fermenta-
tion, the experiment was conducted with a 3-L fermenter 
(BioCNS, Daejeon, South Korea) containing 1 L work-
ing volume. The cultures were carried out at 37  °C with 
150 rpm agitation and 1 vvm air was supplied in the EMK 
medium.
Adaptive laboratory evolution (ALE)
For ALE, a total of 150 serial subcultures were carried out 
once every 24 h in modified EMK medium. The culture 
medium was diluted after reaching stationary phase. Ini-
tially, 1 g/L yeast extract and 5 mM sodium formate were 
supplied. Every 10 serial subcultures, the amount of yeast 
extract was gradually decreased, whereas formate was 
augmented in the culture medium. Then, starting from 
the 100th subculture, the concentration of formate was 
fixed at 20 mM and that of yeast extract at 0.2 g/L. Every 
30th serial subculture, strain selection was carried out 
on agar medium containing a high concentration of for-
mate (100 mM formate, 25 g/L LB broth, and 15 g/L agar 
powder) and the strains that formed large-sized colonies, 
reflecting efficient formate utilization, were selected.
Carbon‑labeling experiment
For carbon-labeling experiments, 10  mM 13C-sodium 
formate (99% purity; Cambridge Isotope Laboratories, 
Inc., Cambridge, MA, USA) was added to the medium. 
Strains were cultured at 37  °C for the times specified 
in the Results. To extract proteinogenic amino acids, 
2–3 mL of culture broth was centrifuged at 13,500  rpm 
for 10 min at 4  °C. After decanting the supernatant, the 
cell pellet was frozen using liquid nitrogen and then dried 
overnight in a freeze dryer (OPERON, South Korea). For 
the hydrolysis of proteins, the pellets were resuspended 
in 200 μL of 6 N HCl and placed at 110 °C for 24 h. Then, 
200 μL of 6 N NaOH were added and mixed thoroughly. 
Samples were stored at − 70 °C until they were analyzed 
by GC–EI-MS. Sample preparation and GC–EI-MS 
analysis were carried out as previously reported [22]. The 
metabolite samples underwent chemical derivatization 
with N-methyl-N-tert-butyldimethylsilyltrifluoroacet-
amide (Sigma-Aldrich, St. Louis, MO, USA) for GC-EI-
MS analysis, and were analyzed using a Bruker 450-GC 
instrument coupled with a Bruker 300-MS single quadru-
pole mass spectrometer (Bruker Inc. Fremont, CA, USA).
Whole genome sequencing
Genomic DNA was purified from wild-type and ALE-
mutant strains using a Wizard Genomic DNA Purifi-
cation Kit (Promega, Madison, WI, USA). The DNA 
library was prepared using a TruSeq DNA PCR-free kit 
(Illumina, Inc., San Diego, CA, USA). The sequencing 
of gDNA was carried out by Macrogen (Daejeon, South 
Korea) using an Illumina Hiseq4000 platform (Illumina, 
San Diego, CA, USA). The overall sequencing was per-
formed according to Macrogen’s standard protocols 
(https ://dna.macro gen.com).
Analytical methods
The optical density was measured using a UV–VIS 
spectrophotometer (model DU-730; Beckman Coulter 
Inc., Fullerton, CA, USA). The metabolite analysis in 
the supernatants was carried out by high-performance 
liquid chromatography (HPLC) using a Waters 2414 
refractive index detector (Waters Corp, Waltham, MA, 
USA) equipped with a Shodex SH1011 column (Sho-
dex, Tokyo, Japan). The column temperature was 75 °C, 
and 10 mM sulfuric acid was used for the mobile phase 
at a flow rate of 0.6 mL/min. The biofilm was detected 
using a Crystal Violet assay (Sigma-Aldrich, St. Louis, 
MO, USA) following the manufacturer’s protocol [23] 
and also analyzed by scanning electron microscopy 
(SEM, Hitachi S-4700, Tokyo, Japan).
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